Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is an **oral multi-ingredient combination** consisting of four pharmaceutical agents—**rosuvastatin, metformin, sitagliptin, and telmisartan**—along with five traditional herbal and spice ingredients: **cinnamon, garlic, ginger, methi dana (fenugreek seeds), and arjun (Terminalia arjuna bark)**. The pharmaceutical components each have established roles: - **Rosuvastatin** is an HMG-CoA reductase inhibitor (statin) used for lowering cholesterol and reducing cardiovascular risk. - **Metformin** is a biguanide antihyperglycemic agent, primarily used for type 2 diabetes. - **Sitagliptin** is a DPP-4 inhibitor for glycemic control in type 2 diabetes. - **Telmisartan** is an angiotensin II receptor blocker (ARB) used for hypertension. The added botanicals and spices are commonly used in traditional medicine: - **Cinnamon** may lower blood glucose and improve lipid profiles by increasing insulin sensitivity and offering antioxidant effects[2][6]. - **Garlic** is cited for its cardioprotective, lipid-lowering, and metabolism-boosting effects, mainly via modulation of cholesterol and vascular tone[6]. - **Ginger** provides anti-inflammatory and digestive benefits and may improve metabolism and glucose handling[6]. - **Methi dana (fenugreek)** contributes fiber, has modest hypoglycemic effects, and aids digestion[2][8]. - **Arjun (Terminalia arjuna)** is valued as a cardiac tonic in Ayurveda, with evidence supporting cardiac muscle strengthening, cholesterol regulation, antihypertensive, and antioxidative actions[4]. This unprecedented combination is not a standard formulation; no single product with this precise set of constituents is listed in pharmaceutical registries or approved by major regulatory authorities. Such complex combinations raise important questions about safety, drug-drug/herb interactions, efficacy, and quality control.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rosuvastatin + metformin + sitagliptin + telmisartan + cinnamon + garlic + ginger + methi dana + arjun.